| Micardis 80 mg tablets EU/1/98/090/005-008 |
Telmisartan |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 40 mg/12.5 mg tablets EU/1/02/213/001-005 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 80 mg/12.5 mg tablets EU/1/02/213/006-010 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MicardisPlus 80 mg/25 mg tablets EU/1/02/213/17-23 |
Telmisartan, Hydrochlorothiazide |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.088 mg tablets EU/1/97/051/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.18 mg tablets EU/1/97/051/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.26 mg prolonged-release tablets EU/1/97/051/13-15 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.35 mg tablets EU/1/97/051/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.52 mg prolonged-release tablets EU/1/97/051/16-18 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 0.7 mg tablets EU/1/97/051/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.05 mg prolonged-release tablets EU/1/97/051/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 1.57 mg prolonged-release tablets EU/1/97/051/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.1 mg prolonged-release tablets EU/1/97/051/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 2.62 mg prolonged-release tablets EU/1/97/051/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| MIRAPEXIN 3.15 mg prolonged-release tablets EU/1/97/051/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Ofev 100 mg Soft capsule EU/1/14/979/001-002 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Ofev 150 mg Soft capsule EU/1/14/979/003-004 |
Nintedanib |
Boehringer Ingelheim International GmbH |
— |
| Ofev 25mg Soft capsule EU/1/14/979/009-012 |
Nintedanib esylate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 110 mg coated granules EU/1/08/442/0029 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 110 mg hard capsules EU/1/08/442/5-8 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg coated granules EU/1/08/442/030 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 150 mg hard capsules EU/1/08/442/009-013 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 20 mg coated granules EU/1/08/442/025 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 30 mg coated granules EU/1/08/442/0026 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 40 mg coated granules EU/1/08/442/0027 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 50 mg coated granules EU/1/08/442/028 |
Dabigatran etexilate mesilate |
Boehringer Ingelheim International GmbH |
— |
| Pradaxa 75 mg hard capsules EU/1/08/442/1-4 |
Dabigatran etexilate |
Boehringer Ingelheim International GmbH |
— |
| Praxbind 2.5 g/50 mL solution for injection/infusion EU/1/15/1056/001 |
Idarucizumab |
Boehringer Ingelheim International GmbH |
— |
| Privigen 100 mg/ml solution for infusion EU/1/08/446/1-3 |
Human normal immunoglobulin |
CSL Behring GmbH |
— |
| Respreeza 1,000 mg powder and solvent for solution for infusion. EU/1/15/1006/001 |
Human alpha1-proteinase inhibitor |
CSL Behring GmbH |
— |
| Rhophylac 300 micrograms/2 ml, solution for injection in pre-filled syringe PA0800/006/002 |
Human anti-D immunoglobulin |
CSL Behring GmbH |
Marketed |
| Riastap 1 g Powder for Solution for Injection/Infusion PA0800/007/001 |
Human fibrinogen |
CSL Behring GmbH |
Not marketed |
| SIFROL 0.088 mg tablets EU/1/97/050/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.18 mg tablets EU/1/97/050/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.26 mg prolonged-release tablets EU/1/97/050/013-015 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.35 mg tablets EU/1/97/050/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.52 mg prolonged-release tablets EU/1/97/050/016-018 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.7 mg tablets EU/1/97/050/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.05 mg prolonged-release tablets EU/1/97/050/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.57 mg prolonged-release tablets EU/1/97/050/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.1 mg prolonged-release tablets EU/1/97/050/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.62 mg prolonged-release tablets EU/1/97/050/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 3.15 mg prolonged-release tablets EU/1/97/050/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution PA0775/009/001 |
Tiotropium, Olodaterol |
Boehringer Ingelheim International GmbH |
Marketed |
| SPIRIVA 18 microgram, inhalation powder, hard capsule PA0775/002/001 |
Tiotropium bromide |
Boehringer Ingelheim International GmbH |
Marketed |
| Spiriva Respimat 2.5 microgram inhalation solution PA0775/002/002 |
Tiotropium bromide |
Boehringer Ingelheim International GmbH |
Marketed |
| Striverdi Respimat 2.5 microgram inhalation solution PA0775/006/001 |
Olodaterol |
Boehringer Ingelheim International GmbH |
Marketed |
| Synjardy 12.5 mg/1,000 mg film-coated tablets EU/1/15/1003/028-036 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |
| Synjardy 12.5 mg/850 mg film-coated tablets EU/1/15/1003/019-027 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |
| Synjardy 5 mg/1,000 mg film-coated tablets EU/1/15/1003/010-018 |
Empagliflozin, Metformin Hydrochloride |
Boehringer Ingelheim International GmbH |
— |